These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18070601)

  • 1. Correlation between Shiga toxin B-subunit stability and antigen crosspresentation: a mutational analysis.
    Pina DG; Stechmann B; Shnyrov VL; Cabanié L; Haicheur N; Tartour E; Johannes L
    FEBS Lett; 2008 Jan; 582(2):185-9. PubMed ID: 18070601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the non-native trifluoroethanol-induced intermediate conformational state of the Shiga toxin B-subunit.
    Pina DG; Gómez J; England P; Craescu CT; Johannes L; Shnyrov VL
    Biochimie; 2006 Sep; 88(9):1199-207. PubMed ID: 16697101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization.
    Haicheur N; Benchetrit F; Amessou M; Leclerc C; Falguières T; Fayolle C; Bismuth E; Fridman WH; Johannes L; Tartour E
    Int Immunol; 2003 Oct; 15(10):1161-71. PubMed ID: 13679386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholera and Shiga toxin B-subunits: thermodynamic and structural considerations for function and biomedical applications.
    Pina DG; Johannes L
    Toxicon; 2005 Mar; 45(4):389-93. PubMed ID: 15733559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrograde transport is not required for cytosolic translocation of the B-subunit of Shiga toxin.
    Garcia-Castillo MD; Tran T; Bobard A; Renard HF; Rathjen SJ; Dransart E; Stechmann B; Lamaze C; Lord M; Cintrat JC; Enninga J; Tartour E; Johannes L
    J Cell Sci; 2015 Jul; 128(13):2373-87. PubMed ID: 25977475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shiga toxin B-subunit binds to the chaperone BiP and the nucleolar protein B23.
    Falguières T; Johannes L
    Biol Cell; 2006 Feb; 98(2):125-34. PubMed ID: 15853775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo tumor targeting by the B-subunit of shiga toxin.
    Viel T; Dransart E; Nemati F; Henry E; Thézé B; Decaudin D; Lewandowski D; Boisgard R; Johannes L; Tavitian B
    Mol Imaging; 2008; 7(6):239-47. PubMed ID: 19123994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly and stability of the shiga toxins investigated by electrospray ionization mass spectrometry.
    Kitova EN; Mulvey GL; Dingle T; Sinelnikov I; Wee S; Griener TP; Armstrong GD; Klassen JS
    Biochemistry; 2009 Jun; 48(23):5365-74. PubMed ID: 19400587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passage through the Golgi is necessary for Shiga toxin B subunit to reach the endoplasmic reticulum.
    McKenzie J; Johannes L; Taguchi T; Sheff D
    FEBS J; 2009 Mar; 276(6):1581-95. PubMed ID: 19220458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shiga toxin B-subunit sequential binding to its natural receptor in lipid membranes.
    Pina DG; Johannes L; Castanho MA
    Biochim Biophys Acta; 2007 Mar; 1768(3):628-36. PubMed ID: 17258170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the carboxyl-terminus amino acids of the Shiga toxin B-subunit on retrograde transport.
    Liu D; Fan Y; Li J; Gao X; Hao M; Xue H; Tai G
    Mol Med Rep; 2012 Jul; 6(1):220-6. PubMed ID: 22552548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of Fluorescent Recombinant Shiga Toxin B Subunit and Its Application to Flow Cytometry.
    Yamaji T
    Methods Mol Biol; 2020; 2132():463-474. PubMed ID: 32306353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional assay for shiga-like toxin via detection by antibody capture and multivalent galabiose binding.
    van Hattum H; van der Zwaluw K; Visser GM; van Putten J; Ruijtenbeek R; Pieters RJ
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7448-50. PubMed ID: 23142616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses of mice immunized with active recombinant shiga toxin and its derivatives.
    Oloomi M; Bouzari S; Ajdary S
    Iran J Allergy Asthma Immunol; 2008 Jun; 7(2):53-60. PubMed ID: 18552406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins.
    Liu J; Sun Y; Feng S; Zhu L; Guo X; Qi C
    Vaccine; 2009 Oct; 27(43):5929-35. PubMed ID: 19682616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells.
    Savina A; Peres A; Cebrian I; Carmo N; Moita C; Hacohen N; Moita LF; Amigorena S
    Immunity; 2009 Apr; 30(4):544-55. PubMed ID: 19328020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmids derived from lambdoid bacteriophages as models for studying replication of mobile genetic elements responsible for the production of Shiga toxins by pathogenic Escherichia coli strains.
    Nejman B; Loś JM; Łoś M; Wegrzyn G; Wegrzyn A
    J Mol Microbiol Biotechnol; 2009; 17(4):211-20. PubMed ID: 19797917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
    Müthing J; Schweppe CH; Karch H; Friedrich AW
    Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification in media composition to obtain secretory production of STxB-based vaccines using Escherichia coli.
    Sadraeian M; Ghoshoon MB; Mohkam M; Karimi Z; Rasoul-Amini S; Ghasemi Y
    Virol Sin; 2013 Feb; 28(1):43-8. PubMed ID: 23329470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.